USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
23 Aug 2022 | 02:45 PM GMT

Incentive Models for HCP & Care Team to Adopt Digital Health in Oncology

Anchored by:

Susan Bratton
CEO
SAVOR HEALTH

Participants:

Susan Bratton CEOSavor Health
Susan Bratton
CEOSavor Health
Ary Deleray Digital Health Business LeaderRoche
Ary Deleray
Digital Health Business LeaderRoche
Chris Wasden Chief Strategy OfficerTwill
Chris Wasden
Chief Strategy OfficerTwill
Holly Spinks Chief Clinical & Compliance OfficerJasper Health
Holly Spinks
Chief Clinical & Compliance OfficerJasper Health
Kevin Darcy Director, Link StrategyVeeva
Kevin Darcy
Director, Link StrategyVeeva
Lynda Chin Co-Founder, President and CEOApricity
Lynda Chin
Co-Founder, President and CEOApricity
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health

About this Meeting

What are the best incentive models to encourage health care professionals (HCPs) and care teams to adopt digital health in oncology? 

Even with the growing interest in using digital tools to empower oncology patients to monitor and manage their symptoms, HCPs and care teams’ adoption still proves to have its challenges. While the growth of partnerships and investments in recent years is a positive sign, the wide range of professionals involved in the journey of oncological patients can make incentive models more complex.  

Join this session to have a peer-to-peer discussion about how digital health companies can build successful incentive models  to improve digital health adoption in oncology: 

  • How can we create incentive models that prove successful for the wide diversity of professionals involved in the oncology patient journey? How do we align their expectations and motivations with patients’ interests?  
  • What are the HCPs and care teams looking for? What are the financial incentives they expect? 
  • It is not all about money. What are the non-financial incentives that can be used to drive adoption? 
  • What can we learn from incentive models in other therapeutic areas? What do digital health companies do wrong?   
  • Adapting incentive models to the different health systems. How can digital health companies build incentive models that efficiently adapt to different health systems?